
Organization · Private Equity
Halisol Groupe
Halisol Groupe is an investment company based in Luxembourg, Paris, and Leiden, focusing on long-term investment strategies in various sectors, primarily in Europe.
Overview
What Halisol Groupe does
What Halisol Groupe is
Halisol Groupe is an investment company based in Luxembourg, Paris, and Leiden, focusing on long-term investment strategies in various sectors, primarily in Europe.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 1994
- Approximate age
- About 32 years
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Halisol Groupe elsewhere
Open the official website or a supported primary organization account.
Capability profile
Halisol Groupe as a funder
Investment thesis
Halisol invests in various sectors with a focus on private equity, private debt, infrastructure, and real estate. The organization targets long-term growth and strategic support for its portfolio companies.
Focus narrative
Halisol invests in various sectors, including pharmaceuticals, leisure, and food services, with a focus on private equity, private debt, infrastructure, and real estate. The company primarily targets investments in Europe, with selective exposure to North America and Asia. Halisol engages in direct investments and co-investments alongside fund managers or other financiers, typically committing between €5 million and €15 million per transaction.
Terms and economics
- Typical check
- $5,000,000–$15,000,000
Focus and fit
- Regions
- AsiaEuropeNorth America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- Pharmafarm and Medix
Portfolio context
Halisol's portfolio includes investments in small, mid, and large-cap LBO funds, venture capital funds, private debt funds, and real estate funds. The company has historically supported pharmaceutical companies such as Pharmafarm and Medix, which have shown growth during Halisol's investment period.
Connected ecosystem
Continue from Halisol Groupe
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Halisol Groupe
Upseed classifies Halisol Groupe under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.